Your browser doesn't support javascript.
loading
An International Multicenter Real-Life Prospective Study of Electronic Chromoendoscopy Score PICaSSO in Ulcerative Colitis.
Iacucci, Marietta; Smith, Samuel C L; Bazarova, Alina; Shivaji, Uday N; Bhandari, Pradeep; Cannatelli, Rosanna; Daperno, Marco; Ferraz, Jose; Goetz, Martin; Gui, Xianyong; Hayee, Bu; De Hertogh, Gert; Lazarev, Mark; Li, Jim; Nardone, Olga M; Parra-Blanco, Adolfo; Pastorelli, Luca; Panaccione, Remo; Occhipinti, Vincenzo; Rath, Timo; Tontini, Gian Eugenio; Vieth, Michael; Villanacci, Vincenzo; Zardo, Davide; Bisschops, Raf; Kiesslich, Ralf; Ghosh, Subrata.
Afiliación
  • Iacucci M; Institute of Immunology and Immunotherapy, NIHR Wellcome Trust Clinical Research Facilities, University of Birmingham, and University Hospitals Birmingham NHS Trust, Birmingham, United Kingdom; National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, Birmingham, United Ki
  • Smith SCL; Institute of Immunology and Immunotherapy, NIHR Wellcome Trust Clinical Research Facilities, University of Birmingham, and University Hospitals Birmingham NHS Trust, Birmingham, United Kingdom.
  • Bazarova A; Institute of Immunology and Immunotherapy, NIHR Wellcome Trust Clinical Research Facilities, University of Birmingham, and University Hospitals Birmingham NHS Trust, Birmingham, United Kingdom; Institute for Biological Physics, University of Cologne, Cologne, Germany.
  • Shivaji UN; Institute of Immunology and Immunotherapy, NIHR Wellcome Trust Clinical Research Facilities, University of Birmingham, and University Hospitals Birmingham NHS Trust, Birmingham, United Kingdom; National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, Birmingham, United Ki
  • Bhandari P; Division of Gastroenterology, Queen Alexandra Hospital, Portsmouth, United Kingdom.
  • Cannatelli R; Institute of Immunology and Immunotherapy, NIHR Wellcome Trust Clinical Research Facilities, University of Birmingham, and University Hospitals Birmingham NHS Trust, Birmingham, United Kingdom; Department of Gastroenterology, Spedali Civili, Brescia, Italy.
  • Daperno M; Division of Gastroenterology, University of Torino, Torino, Italy.
  • Ferraz J; Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Canada.
  • Goetz M; Division of Gastroenterology, Klinikum Böblingen, Germany.
  • Gui X; Division of Gastroenterology, University of Washington, Seattle, Washington.
  • Hayee B; Division of Gastroenterology, Kings College London, London, United Kingdom.
  • De Hertogh G; Division of Gastroenterology, University Hospitals Leuven, Belgium.
  • Lazarev M; Division of Gastroenterology, Johns Hopkins Hospital, Baltimore, Maryland.
  • Li J; Division of Gastroenterology, Peking Union Medical College Hospital, Beijing, China.
  • Nardone OM; Institute of Immunology and Immunotherapy, NIHR Wellcome Trust Clinical Research Facilities, University of Birmingham, and University Hospitals Birmingham NHS Trust, Birmingham, United Kingdom.
  • Parra-Blanco A; Division of Gastroenterology, University of Nottingham, Nottingham, United Kingdom.
  • Pastorelli L; Division of Gastroenterology, IRCCS Policlinico San Donato, Milan, Italy.
  • Panaccione R; Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Canada.
  • Occhipinti V; Division of Gastroenterology, IRCCS Policlinico San Donato, Milan, Italy.
  • Rath T; Division of Gastroenterology, University of Erlangen, Erlangen, Germany.
  • Tontini GE; Division of Gastroenterology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
  • Vieth M; Klinikum Bayreuth, Bayreuth, Germany.
  • Villanacci V; Institute of Pathology, Spedali Civili, Brescia, Italy.
  • Zardo D; Division of Gastroenterology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
  • Bisschops R; Division of Gastroenterology, University Hospitals Leuven, Belgium.
  • Kiesslich R; Helios HSK Wiesbaden, Wiesbaden, Germany.
  • Ghosh S; Institute of Immunology and Immunotherapy, NIHR Wellcome Trust Clinical Research Facilities, University of Birmingham, and University Hospitals Birmingham NHS Trust, Birmingham, United Kingdom; National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, Birmingham, United Ki
Gastroenterology ; 160(5): 1558-1569.e8, 2021 04.
Article en En | MEDLINE | ID: mdl-33347880
ABSTRACT
BACKGROUND &

AIMS:

Endoscopic and histologic remission are important goals in the treatment of ulcerative colitis (UC). We investigated the correlation of the recently developed Paddington International Virtual ChromoendoScopy ScOre (PICaSSO) and other established endoscopic scores against multiple histological indices and prospectively assessed outcomes.

METHODS:

In this prospective multicenter international study, inflammatory activity was assessed with high-definition and virtual chromoendoscopy in the rectum and sigmoid using the Mayo Endoscopic Score (MES), UC Endoscopic Index of Severity (UCEIS), and PICaSSO. Targeted biopsies were taken for assessment using Robarts Histological Index (RHI), Nancy Histological index (NHI), ECAP (Extent, Chronicity, Activity, Plus score), Geboes, and Villanacci. Follow-up data were obtained at 6 and 12 months after colonoscopy.

RESULTS:

A total of 307 patients were recruited. There was strong correlation between PICaSSO and histology scores, significantly superior to correlation coefficients of MES and UCEIS with histology scores. A PICaSSO score of ≤3 detected histologic remission by RHI (≤3 + absence of neutrophils) with area under the receiver operating characteristic curve (AUROC) 0.90 (95% confidence interval [CI] 0.86-0.94) and NHI (≤1) AUROC 0.82 (95% CI 0.77-0.87). The interobserver agreement for PICaSSO was 0.88 (95% CI 0.83-0.92). At 6- and 12-months follow-up, PICaSSO score ≤3 predicted better outcomes than PICaSSO >3 (hazard ratio [HR] 0.19 [0.11-0.33] and 0.22 [0.13-0.34], respectively),} as well as PICaSSO 4-8 (HR 0.25 [0.12-0.53] and 0.22 (0.12-0.39), respectively) and similar to histologic remission.

CONCLUSION:

In this first real-life multicenter study, the PICaSSO score correlated strongly with multiple histological indices. Furthermore, PICaSSO score predicted specified clinical outcomes at 6 and 12 months, similar to histology. Thus, PICaSSO can be a useful endoscopic tool in the therapeutic management of UC.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Recto / Interpretación de Imagen Asistida por Computador / Colitis Ulcerosa / Técnicas de Apoyo para la Decisión / Diagnóstico por Computador / Colonoscopía / Colon Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Gastroenterology Año: 2021 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Recto / Interpretación de Imagen Asistida por Computador / Colitis Ulcerosa / Técnicas de Apoyo para la Decisión / Diagnóstico por Computador / Colonoscopía / Colon Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Gastroenterology Año: 2021 Tipo del documento: Article